Roseola medical therapy: Difference between revisions
Jump to navigation
Jump to search
Line 7: | Line 7: | ||
==Medical therapy== | ==Medical therapy== | ||
The mainstay of therapy for roseola is supportive as HHV 6 typically causes a | The mainstay of therapy for roseola is supportive as HHV 6 typically causes a benign, self limited illness in infants and antiviral therapy is not indicated. | ||
*Supportive therapy for roseola includes antipyretics such as acetaminophen if associated with discomfort | *Supportive therapy for roseola includes antipyretics such as acetaminophen if associated with discomfort | ||
*Rash typically dissappears after 2 days. | *Rash typically dissappears after 2 days. |
Revision as of 11:58, 25 May 2017
Roseola Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Roseola medical therapy On the Web |
American Roentgen Ray Society Images of Roseola medical therapy |
Risk calculators and risk factors for Roseola medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Medical therapy
The mainstay of therapy for roseola is supportive as HHV 6 typically causes a benign, self limited illness in infants and antiviral therapy is not indicated.
- Supportive therapy for roseola includes antipyretics such as acetaminophen if associated with discomfort
- Rash typically dissappears after 2 days.
References
McInerny, Thomas (2017). American Academy of Pediatrics textbook of pediatric care. Elk Grove Village, IL: American Academy of Pediatrics. ISBN 978-1-58110-966-5.